Why has the Queensland health department withdrawn funding for its award-winning QoVax research program studying the safety and efficacy of Covid-19 vaccines?
Only last August, Queensland’s Health Minister, Yvette D’Ath, and the chief operating officer of Queensland Health, Dr David Rosengren, celebrated the work of the QoVax team, led by Professor Janet Davies, which was a highly commended finalist in the Pursuing Innovation category at the 2022 Queensland Health Awards for Excellence.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in